OTCMKTS:BGMD - BG Medicine Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.0180 +0.01 (+125.00 %) (As of 03/22/2019 04:00 PM ET)Previous Close$0.0180Today's Range$0.0180 - $0.018052-Week Range$0.01 - $0.0750Volume4,000 shsAverage Volume5,405 shsMarket Capitalization$204,660.00P/E RatioN/ADividend YieldN/ABeta2.67 ProfileDiscussionChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. It has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc. for the automated instrument versions of galectin-3 test; and a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts. Receive BGMD News and Ratings via Email Sign-up to receive the latest news and ratings for BGMD and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Diagnostic substances Sub-IndustryLife Sciences Tools & Services SectorMedical Current SymbolOTCMKTS:BGMD Previous SymbolNASDAQ:BGMD CUSIP08861T10 CIK1407038 Webwww.bg-medicine.com Phone781-890-1199Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares11,370,000Market Cap$204,660.00 Next Earnings DateN/A OptionableNot Optionable BG Medicine (OTCMKTS:BGMD) Frequently Asked Questions What is BG Medicine's stock symbol? BG Medicine trades on the OTCMKTS under the ticker symbol "BGMD." How were BG Medicine's earnings last quarter? BG Medicine, Inc. (OTCMKTS:BGMD) announced its quarterly earnings data on Tuesday, November, 17th. The medical research company reported ($0.27) earnings per share (EPS) for the quarter. The medical research company earned $334 million during the quarter, compared to analysts' expectations of $695 million. View BG Medicine's Earnings History. Has BG Medicine been receiving favorable news coverage? Media coverage about BGMD stock has been trending somewhat positive on Saturday, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. BG Medicine earned a news sentiment score of 0.9 on InfoTrie's scale. They also gave media stories about the medical research company a news buzz of 2.0 out of 10, indicating that recent media coverage is very unlikely to have an effect on the stock's share price in the next several days. Who are some of BG Medicine's key competitors? Some companies that are related to BG Medicine include IDEXX Laboratories (IDXX), IPSEN S A/S (IPSEY), Immunomedics (IMMU), Neogen (NEOG), Quidel (QDEL), Myriad Genetics (MYGN), Lantheus (LNTH), Intellia Therapeutics (NTLA), Meridian Bioscience (VIVO), Quotient (QTNT), Oxford Immunotec Global (OXFD), Palatin Technologies (PTN), Nymox Pharmaceutical (NYMX), Vermillion (VRML) and Trinity Biotech (TRIB). What other stocks do shareholders of BG Medicine own? Based on aggregate information from My MarketBeat watchlists, some companies that other BG Medicine investors own include Micron Technology (MU), Glu Mobile (GLUU), Blue Ridge Mountain Resources (MHRCQ), Nektar Therapeutics (NKTR), Arca Biopharma (ABIO), On Track Innovations (OTIV), Catalyst Pharmaceuticals (CPRX), Inovio Pharmaceuticals (INO), AEterna Zentaris (AEZS) and McEwen Mining (MUX). Who are BG Medicine's key executives? BG Medicine's management team includes the folowing people: Dr. Paul R. Sohmer, CEO, Pres & Director (Age 70)Mr. Stephen P. Hall, CFO, Exec. VP & Treasurer (Age 68)Dr. Aram Adourian, Chief Scientific Officer (Age 49) How do I buy shares of BG Medicine? Shares of BGMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is BG Medicine's stock price today? One share of BGMD stock can currently be purchased for approximately $0.0180. How big of a company is BG Medicine? BG Medicine has a market capitalization of $204,660.00. What is BG Medicine's official website? The official website for BG Medicine is http://www.bg-medicine.com. How can I contact BG Medicine? BG Medicine's mailing address is 303 Wyman Street Suite 300, Waltham MA, 02451. The medical research company can be reached via phone at 781-890-1199 or via email at [email protected] MarketBeat Community Rating for BG Medicine (OTCMKTS BGMD)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 76 (Vote Outperform)Underperform Votes: 89 (Vote Underperform)Total Votes: 165MarketBeat's community ratings are surveys of what our community members think about BG Medicine and other stocks. Vote "Outperform" if you believe BGMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BGMD will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/23/2019 by MarketBeat.com StaffFeatured Article: What does cost of debt say about a company’s financial health?